Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
Pastor
N
N
Betlloch
I
I
Pascual
J C
JC
Blanes
M
M
Bañuls
J
J
Silvestre
J F
JF
D000369:Aged, 80 and over; D000068800:Etanercept; D005260:Female; D016523:Foot Ulcer / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept